For: | Wang MQ, Li YP, Xu M, Tian Y, Wu Y, Zhang X, Shi JJ, Dang SS, Jia XL. VCAN, expressed highly in hepatitis B virus-induced hepatocellular carcinoma, is a potential biomarker for immune checkpoint inhibitors. World J Gastrointest Oncol 2022; 14(10): 1933-1948 [PMID: 36310697 DOI: 10.4251/wjgo.v14.i10.1933] |
---|---|
URL: | https://www.wjgnet.com/1948-5204/full/v14/i10/1933.htm |
Number | Citing Articles |
1 |
Zhenbang Ye, Ning Huang, Yongliang Fu, Rongle Tian, Liming Wang, Wenting Huang. Tumor purity-related genes for predicting the prognosis and drug sensitivity of DLBCL patients. eLife 2024; 13 doi: 10.7554/eLife.92841.3
|
2 |
Shanqi Li, Yuzhou Qian, Wanchen Xie, Xinyu Li, Jiaying Wei, Long Wang, Guosheng Ren, Xuedong Yin. Identification and validation of neutrophils-related subtypes and prognosis model in triple negative breast cancer. Journal of Cancer Research and Clinical Oncology 2024; 150(3) doi: 10.1007/s00432-024-05651-3
|
3 |
Hao Chi, Songyun Zhao, Jinyan Yang, Xinrui Gao, Gaoge Peng, Jinhao Zhang, Xixi Xie, Guobin Song, Ke Xu, Zhijia Xia, Shi Chen, Jinqiu Zhao. T-cell exhaustion signatures characterize the immune landscape and predict HCC prognosis via integrating single-cell RNA-seq and bulk RNA-sequencing. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1137025
|
4 |
Yunhe Liu, Ansam Sinjab, Jimin Min, Guangchun Han, Francesca Paradiso, Yuanyuan Zhang, Ruiping Wang, Guangsheng Pei, Yibo Dai, Yang Liu, Kyung Serk Cho, Enyu Dai, Akshay Basi, Jared K. Burks, Kimal I. Rajapakshe, Yanshuo Chu, Jiahui Jiang, Daiwei Zhang, Xinmiao Yan, Paola A. Guerrero, Alejandra Serrano, Mingyao Li, Tae Hyun Hwang, Andrew Futreal, Jaffer A. Ajani, Luisa M. Solis Soto, Amir A. Jazaeri, Humam Kadara, Anirban Maitra, Linghua Wang. Conserved spatial subtypes and cellular neighborhoods of cancer-associated fibroblasts revealed by single-cell spatial multi-omics. Cancer Cell 2025; doi: 10.1016/j.ccell.2025.03.004
|
5 |
Wei Yan, Lin Qiu, Meiling Yang, Anran Xu, Manqi Ma, Qinzi Yuan, Xiaochen Ma, Wenjuan Liang, Xuenong Li, Yanxia Lu. CXCL10 mediates CD8+ T cells to facilitate vessel normalization and improve the efficacy of cetuximab combined with PD-1 checkpoint inhibitors in colorectal cancer. Cancer Letters 2023; 567: 216263 doi: 10.1016/j.canlet.2023.216263
|
6 |
Xinrong Lin, Chuan Tian, Fan Pan, Rui Wang. A novel immune-associated prognostic signature based on the immune cell infiltration analysis for hepatocellular carcinoma. Oncologie 2024; 26(1): 91 doi: 10.1515/oncologie-2023-0360
|
7 |
Lifei Deng, Hong Ran, Dunhui Yang, Zhen Wang, Peng Zhao, Hengjie Huang, Yongjin Wu, Peng Zhang. TOM40 as a prognostic oncogene for oral squamous cell carcinoma prognosis. BMC Cancer 2025; 25(1) doi: 10.1186/s12885-024-13417-w
|